Latest News & Updates

Breaking News

  • 7 minutes ago

  • Vaibhavi M.

Nxera Licenses GPCR Program To NewCo, Secures Equity Stake And Future Royalties, Partners With Investor-Backed NewCo To Advance GPCR Asset Globally
Breaking News
Mesoblast Presents New Data Supporting Early Use of Ryoncil® And Pivotal Trial In Adult SR-aGvHD

Vaibhavi M.

Vaxcyte Initiates OPUS-3 Phase 3 Trial Of VAX-31 in Previously Vaccinated Adults, First Patients Dosed In Pneumococcal Vaccine

Vaibhavi M.

Biogen Appoints Dr Maria C. Freire As New Chair Of The Board, Succeeding Caroline Dorsa, Following The 2026 Annual Meeting

Vaibhavi M.

Thermo Fisher And Datavant Partner To Advance Real-World Data Integration In Clinical Research, Expands RWE Capabilities Through Strategic Data Collaboration

Vaibhavi M.

Other trending news you may like to read

Nxera Licenses GPCR Program To NewCo, Secures Equity Stake And Future Royalties, Partners With Investor-Backed NewCo To Advance GPCR Asset Globally

Nxera licenses its GPCR program to a NewCo-backed partner, securing equity, milestones, and future royalties.

Vaibhavi M.

Pharma Now

Mesoblast Presents New Data Supporting Early Use of Ryoncil® And Pivotal Trial In Adult SR-aGvHD

Mesoblast shares new data showing early Ryoncil® use improves outcomes and supports a pivotal adult SR-aGvHD trial.

Vaibhavi M.

Pharma Now

Vaxcyte Initiates OPUS-3 Phase 3 Trial Of VAX-31 in Previously Vaccinated Adults, First Patients Dosed In Pneumococcal Vaccine

Vaxcyte doses first patients in OPUS-3 Phase 3 trial of VAX-31 in previously vaccinated adults.

Vaibhavi M.

Pharma Now

Biogen Appoints Dr Maria C. Freire As New Chair Of The Board, Succeeding Caroline Dorsa, Following The 2026 Annual Meeting

Biogen names Dr. Maria C. Freire as Board Chair, succeeding Caroline Dorsa after the 2026 Annual Meeting.

Vaibhavi M.

Pharma Now